 |
|
Treatment of high-risk neuroblastoma
Ki Woong Sung (Sung KW)
Clin Exp Pediatr. 2012;55(4):115-120. Published online 2012 Apr 30 DOI: https://doi.org/10.3345/kjp.2012.55.4.115
|
|
Citations to this article as recorded by
 Autologous or allogeneic hematopoietic stem cells transplantation combined with high-dose chemotherapy for refractory neuroblastoma
Zhang-Shuai Zhao, Wei Shao, Ji-Ke Liu
Medicine.2021; 100(49): e28096. CrossRef Opportunities and challenges of circulating biomarkers in neuroblastoma
Ricky M. Trigg, Jacqui A. Shaw, Suzanne D. Turner
Open Biology.2019;[Epub] CrossRef Preclinical Pharmacokinetics and Dosimetry Studies of 124I/131I-CLR1404 for Treatment of Pediatric Solid Tumors in Murine Xenograft Models
Ian R. Marsh, Joseph Grudzinski, Dana C. Baiu, Abigail Besemer, Reinier Hernandez, Justin J. Jeffery, Jamey P. Weichert, Mario Otto, Bryan P. Bednarz
Journal of Nuclear Medicine.2019; 60(10): 1414. CrossRef
|